A Multicenter, Randomized, Double-blind, Placebo-controlled Phase IIa Study to Explore the Efficacy, Safety, and Pharmacokinetic Profile of HWH486 in Adults With Chronic Spontaneous Urticaria(CSU)
Latest Information Update: 14 Mar 2024
At a glance
- Drugs HWH 486 (Primary)
- Indications Chronic urticaria
- Focus Therapeutic Use
- Sponsors Hubei Biological Medicine Industrial Technology Institute
- 08 Mar 2024 New trial record